PLUS1
Best deals to access real time data! |
|
SMALL CAP BASIC
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Galectin Therapeutics Inc. | GALT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.19 | -3.71% | 4.93 | 5.1799 | 4.79 | 5.12 | 5.12 | 14:37:53 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.93 | 4.95 | 0.02 | 0.40% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 717 | 160,848 | $ 4.9662 | $ 798.81k | 635.74k | 1.28 - 9.49 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:37:53 | 100 | $4.93 | USD |
Galectin Therapeutics Inc. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 204.16M | 40.91M | $ -16.24M | -0.49 | 0.00 | 31.89M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | -52.37k | 13.10% |
Galectin Therapeutics Inc. News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/15/2018 | 10:22 | GlobeNewswire Inc. | Galectin Therapeutics to Participate in The ROTH Capital.. |
| 10/15/2018 | 08:00 | GlobeNewswire Inc. | Galectin Therapeutics to Present at The ROTH Capital Battle.. |
| 9/28/2018 | 16:36 | Edgar (US Regulatory) | Amended Quarterly Report (10-q/a) |
| 9/28/2018 | 16:34 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) |
| 9/26/2018 | 08:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 9/25/2018 | 12:31 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) |
| 9/20/2018 | 08:00 | GlobeNewswire Inc. | Galectin Therapeutics, Inc. Announces Positive Preliminary.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GALT Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 5.17 | 5.24 | 4.5701 | 4.9010 | 219k | 603k | 392k | -0.24 | -4.64% |
| 1 Month | 6.06 | 6.98 | 4.5701 | 5.9648 | 191k | 2M | 636k | -1.13 | -18.65% |
| 3 Months | 5.42 | 6.98 | 3.531 | 5.4273 | 191k | 3M | 668k | -0.49 | -9.04% |
| 6 Months | 3.45 | 9.49 | 3.1 | 5.9896 | 84k | 6M | 761k | 1.48 | 42.90% |
| 1 Year | 2.3 | 9.49 | 1.28 | 4.8792 | 84k | 7M | 737k | 2.63 | 114.35% |
| 3 Years | 2.86 | 9.49 | 0.49 | 3.5250 | 13k | 8M | 449k | 2.07 | 72.38% |
| 5 Years | 11.7 | 19.1099 | 0.49 | 5.4006 | 13k | 8M | 404k | -6.77 | -57.86% |
Galectin Therapeutics Inc. Description
| Galectin Therapeutics, Inc. offers drug research & development to create new therapies for fibrotic disease & cancer. It has two compounds in development; one to be used in treatment of liver fibrosis & fatty liver disease & the other in cancer therapy. |
